Table 3.
Risk of bias for randomized controlled trials in patients with Takayasu arteritis
| Study (reference no) | Intervention | Randomization | Effect of assignmentof intervention | Missing outcomedata | Measurementof outcome | Selection ofreported result | Overall |
|---|---|---|---|---|---|---|---|
| Langford 2017 (63) | Abatacept | Some concern | Low | Low | Low | Low | Some concern |
| Shao 2017 (65) | Curcumin | Some concern | High | Some concern | High | High | High |
| Shi 2016 (66) | Resveratrol | Some concern | High | Low | High | High | High |
| Nakaoka 2018 (72) | Tocilizumab | Some concern | Low | Low | Low | Some concern | Some concern |